Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:EXAM

(EXAM) (EXAM) Stock Price, News & Analysis

(EXAM) logo

About (EXAM) Stock (NYSE:EXAM)

Advanced Chart

Key Stats

Today's Range
$35.05
$35.17
50-Day Range
N/A
52-Week Range
$21.98
$37.26
Volume
3.56 million shs
Average Volume
660,679 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.

Receive EXAM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter.

EXAM Stock News Headlines

Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?
See More Headlines

EXAM Stock Analysis - Frequently Asked Questions

(EXAM) (NYSE:EXAM) released its quarterly earnings results on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, meeting the consensus estimate of $0.08. The business's quarterly revenue was up 15.4% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that (EXAM) investors own include Bristol-Myers Squibb (BMY), Ciena (CIEN), Best Buy (BBY), China Biologic Products (CBPO), Community Health Systems (CYH), Diplomat Pharmacy (DPLO) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/10/2016
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Services
Current Symbol
NYSE:EXAM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:EXAM) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners